Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

TheraTech receives NIH funding for novel approach to rheumatoid arthritis

Sep. 24, 1998

Mitsui Chemicals prepares cell adhesion inhibitors

Sep. 24, 1998

PAF antagonist evaluated in patients with rheumatoid arthritis; results disappointing

Sep. 22, 1998

Novel antiinflammatory azulenes disclosed by Kotobuki

Sep. 21, 1998

Selective and sensitive p38 MAP kinase inhibitor identified by SmithKline Beecham

Sep. 18, 1998

La Jolla identifies target of antibodies responsible for life-threatening autoimmune disorder

Sep. 17, 1998

Medical device for rheumatoid arthritis scheduled for October advisory panel review

Sep. 17, 1998

Advisory committee unanimously recommends approval for Enbrel

Sep. 17, 1998

Viragen acquires stake in Inflammatics; adds LeukoVAX to pipeline

Sep. 15, 1998

FDA approves, HMR begins shipping new treatment for adult rheumatoid arthritis

Sep. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...